The Bioabsorbable Stents Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for bioabsorbable stents has witnessed significant growth recently. The market size is projected to increase from $0.37 billion in 2024 to $0.41 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%.
The Bioabsorbable Stents Global Market is forecasted to reach a size of $0.59 billion by the year 2029. This growth is expected to occur at a compound annual growth rate (CAGR) of 9.8%.
Download Your Free Sample of the 2025 Bioabsorbable Stents Market Report and Uncover Key Trends Now!The key drivers in the bioabsorbable stents market are:
• Expanded clinical indications for the use of bioabsorbable stents
• Customization and personalization of the stents
• Global expansion of the bioabsorbable stents market
• Increasing preference for patient-friendly options
The bioabsorbable stents market covered in this report is segmented –
1) By Product Type: Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents
2) By Absorption Rate: Slow- Absorption Stents, Fast- Absorption Stents
3) By Applications: Coronary Artery Diseases, Peripheral Artery Diseases
The key trends in the bioabsorbable stents market are:
• Advancements in bioabsorbable materials are a crucial emerging trend.
• The sector is set to be shaped by clinical advancements and increased research data.
• The development of hybrid stent designs is a significant future trend.
• The market is experiencing a growing trend of collaborations and partnerships.
Major companies in the bioabsorbable stents market are:
• Abbott Laboratories
• REVA Medical Inc.
• Elixir Medical Corporation
• Biotronik SE & Co. KG
• Amaranth Medical Inc.
• Zorion Medical Inc.
• Tepha Inc.
• S3V Vascular Technologies
• ICON Interventional Systems Inc.
• Arterius Limited
• Microport Scientific Corporation
• Meril Life Sciences Pvt. Ltd.
• Medlogics Device Corporation
• B. Braun Melsungen AG
• Boston Scientific Corporation
• C.R. Bard Inc.
• Stentys SA
• Terumo Corporation
• OrbusNeich
• Arterial Remodeling Technologies
• Cardionovum GmbH
• Envision Scientific Pvt Ltd.
• Eurocor GmbH
• Hexacath
• Kyoto Medical Planning Co. Ltd.
• Lifetech Scientific (Shenzhen) Co. Ltd.
• Manli Cardiology Limited
• Medtronic Inc.
• QualiMed Innovative Medizinprodukte GmbH
• Sahajanand Medical Technologies Pvt. Ltd.
• Sinomed
• Surmodics Inc.
• Translumina Therapeutics
• Vascular Concepts Limited
• Xenogenics Corporation
North America was the largest region in the bioabsorbable stents market in 2023